Research programme: diabetes/lipid metabolism disorder therapeutics - Indigene PharmaceuticalsAlternative Names: IG-MD-011
Latest Information Update: 16 Jul 2016
At a glance
- Originator Indigene Pharmaceuticals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Diabetes mellitus; Lipid metabolism disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Diabetes-mellitus in India
- 16 Jul 2016 No recent reports of development identified for research development in Lipid-metabolism-disorders in India
- 07 Oct 2009 Early research in Lipid metabolism disorders in India (unspecified route)